Immunic (IMUX) Exchange Rate Effect (2013 - 2026)
Immunic's (IMUX) quarterly Exchange Rate Effect came in at -$193000.0 in Q1 2026, down 142.05% year-on-year from $459000.0 in Q1 2025, and up 53.61% quarter-over-quarter from -$416000.0 in Q4 2025.
Immunic (IMUX) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Immunic has disclosed Exchange Rate Effect across 14 years of filings, most recently posting -$193000.0 for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$193000.0, down 142.05% year-over-year; the trailing twelve-month figure through Mar 2026 was -$447000.0 (down 92.67% YoY), and the FY2025 annual result was $205000.0, up 139.65% from the prior year.
- Exchange Rate Effect came in at -$193000.0 for Q1 2026 at Immunic, up from -$416000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $2.7 million in Q4 2022 to a low of -$1.9 million in Q2 2022.
- The 5-year median for Exchange Rate Effect is $29000.0 (2025), against an average of -$72705.9.
- Across the five-year window, Exchange Rate Effect surged 479.63% in 2022 and plunged 612.99% in 2024, its largest moves.
- Immunic's Exchange Rate Effect stood at $2.7 million in 2022, then sank by 78.5% to $573000.0 in 2023, then sank by 189.7% to -$514000.0 in 2024, then increased by 19.07% to -$416000.0 in 2025, then surged by 53.61% to -$193000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$193000.0 (Q1 2026), -$416000.0 (Q4 2025), and $29000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 8.68 Mn |
| 10 | Immunic | 384.84 Mn | 198.21 Mn | - | -193,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -193,000.00 |
| Mar 31, 2026 | -193,000.00 |
| Dec 31, 2025 | -416,000.00 |
| Dec 31, 2025 | -416,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 133,000.00 |
| Jun 30, 2025 | 133,000.00 |
| Mar 31, 2025 | 459,000.00 |
| Mar 31, 2025 | 459,000.00 |
| Dec 31, 2024 | -514,000.00 |
| Dec 31, 2024 | -514,000.00 |
| Sep 30, 2024 | 218,000.00 |
| Sep 30, 2024 | 218,000.00 |
| Jun 30, 2024 | -395,000.00 |
| Jun 30, 2024 | -395,000.00 |
| Mar 31, 2024 | 174,000.00 |
| Mar 31, 2024 | 174,000.00 |
| Dec 31, 2023 | 573,000.00 |
| Dec 31, 2023 | 573,000.00 |